BPC-157 + TB-500 — Lot BB20 — Accession 2606080482

← All lot records
Lot record

Body Protection Compound 157 + Thymosin Beta-4 Fragment, lot BB20

A vial from this lot was sent to Freedom Diagnostics for independent analysis. This page is the record of what came back, published whole and unedited.
Released 10 mg vial Lab No. 2606080482
Laboratory
Freedom Diagnostics
Sample received
8 June 2026
Results reported
9 June 2026
BATCH
VERIFICATION
LOT NUMBER
BB20
10 mg vial
IDENTITY
Confirmed
CHROMATOGRAPHIC PURITY
99.32%
NET CONTENT — AC-SDKP
11.8 mg
Analytical characterization

Every result against its specification.

Lot BB20 · 10 mg vial · Freedom Diagnostics · reported 9 June 2026 . The bar shows where the reported result falls against Astramide’s published release criterion. The notch marks the criterion.
Within criterion Below label claim Above criterion Failed Not on this COA
Test
Method
Criterion
Result
Result vs criterion
Status
Identity
LC-MS
LC-MS match to the labelled compound
Confirmed
WITHIN SPEC
Chromatographic purity
HPLC-UV
at or above 98.0%
99.32%
95 at or above 98.0% 100
WITHIN SPEC
Net content — Ac-SDKP
HPLC-UV
at or above label claim
11.8 mg
80 at or above label claim 120
WITHIN SPEC
Net content — BPC-157
HPLC-UV
at or above label claim
11.22 mg
80 at or above label claim 120
WITHIN SPEC
Endotoxin
LAL, USP <85>
below the 0.05 EU/mL assay sensitivity
Pass, 2 of 2 at ≤0.05 EU/mL
WITHIN SPEC
Appearance
Visual
white lyophilized powder
White Lyophilized Powder
WITHIN SPEC
Values are reported per vial unless otherwise noted. Every figure here is taken from the batch Certificate of Analysis and nothing else.
Certificate of Analysis
Body Protection Compound 157 + Thymosin Beta-4 Fragment · Lot BB20 · 10 mg vial · Lab No. 2606080482
Download Full screen
Your browser cannot display the report inline. Open the PDF.
Freedom Diagnostics · 1 page · served inline, not a screenshot
Quick reference

How to read this report

Same six keys on every Astramide product page. Only the values change.
1Lot numberMatch it to the number printed on your vial. If they differ, this report is not for your vial.
2IdentityMass spectrometry confirms the molecule is the one on the label. It conforms or it does not. There is no partial result.
3Chromatographic purityThe share of the material that is the target peptide. A purity figure quoted without a method is not a purity figure.
4Net content, and percent of labelHow much peptide is in the vial against what the label claims. A different question from purity. High purity with low content means clean material in an under-filled vial.
5EndotoxinMeasured against a ceiling, not a floor. Sensitivity differs by laboratory, so results are not compared across labs.
6Laboratory, method, dateWho ran it, on what instrument, and when. A report with no named laboratory or no date is not a report.

What does this record cover?

One lot, and one lot only: lot BB20, in the 10 mg vial. Results from one lot do not carry over to the next. Match the lot number printed on your vial to the lot number on this page before you rely on any figure here. If the two differ, this is not the report for your vial.

Who ran the testing?

Freedom Diagnostics ran the analysis. Astramide does not test its own material and does not report its own numbers. How we test sets out which laboratories we use and what each method measures.

Where is the original document?

The Certificate of Analysis above is the laboratory’s own PDF, served whole and downloadable. It is not a screenshot, a transcription or a summary. Every figure on this page is read from it. Every lot we have tested is published the same way, including the ones we rejected.

Where can this compound be found?

Body Protection Compound 157 + Thymosin Beta-4 Fragment carries its full batch history, including this lot. Research use only.

Research use only

All products sold by Astramide are intended exclusively for laboratory research purposes. They are not intended for human consumption, medical, therapeutic, or diagnostic use.